针对性纳米颗粒用于怀孕的 rhesus macaques 中的胎盘特定药物输送
Jenna K Schmidt1,2, Ann M Mitzey1, Logan T Keding1,2
1Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA.
Theranostics
|December 22, 2025
概括
装饰着iRGD的向脂质体选择性地积聚在灵长类动物的胎盘中,而不会影响胎儿的发育. 这种纳米粒子配方显示出在人类怀孕期间安全,向的胎盘药物输送的前景.
科学领域:
- 生物医学工程 生物医学工程
- 产科和妇科 产科和妇科
- 纳米医学是一种纳米医学.
背景情况:
- 在怀孕期间全身药物管理存在风险.
- 胎盘功能障碍需要新的治疗策略.
- 以前的研究开发了脂肪体,用于小鼠的胎向分娩.
研究的目的:
- 评估非人类灵长类动物中iRGD装饰脂质体的选择性胎盘积累.
- 评估母亲对脂质体输液的全身反应.
- 为了确定脂肪体的胎儿转移.
主要方法:
- 脂质体被设计为有胎盘指向性 (iRGD) 或非向性 (ARA) .
- 脂质细胞被静脉注射到怀孕的 rhesus macaques 在不同的妊娠阶段.
- 输液后24小时,分析了母体和组织样本,以确定脂质体分布和母体反应.
主要成果:
- 脂质体输液耐受性很好,对母亲或胎儿的健康没有不良影响.
- 选择性地在胎盘中积累的iRGD-脂质体,对其他母体器官的分布最小.
- 非向的ARA脂质体显示在母体,子宫胎盘和胎儿组织中广泛分布.
- 没有观察到脂质体转移到胎儿.
结论:
- 装饰iRGD的脂质体在 rhesus的胎盘中体内选择性积累.
- 纳米粒子配方与短期治疗兼容,并且没有显示胎儿转移.
- 这种向性脂质体方法有可能在人类怀孕中提供治疗有效载荷.
更多相关视频
05:55Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles
Published on: September 18, 2018
9.2K
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
10.0K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
